Registration number: 16001748

Collabio Ltd

trading as Collabio

Contents

Company Information	1
Balance Sheet	2
Notes to the Unaudited Financial Statements	3 to 6

Collabio Ltd

trading as Collabio

Company Information

Director

Graeme Arthur Peacock

Registered office

4 Livings Way Stansted CM24 8SN

Accountants

Andrew J Fraser 2 Bisham House Woodside Gardens Marlow Buckinghamshire SL7 1FQ

Collabio Ltd

trading as Collabio

(Registration number: 16001748)
Balance Sheet as at 31 October 2025

	Note	2025 £
Fixed assets
Tangible assets	4	5,199
Current assets
Cash at bank and in hand		104,257
Creditors: Amounts falling due within one year	5	(80,897)
Net current assets		23,360
Net assets		28,559
Capital and reserves
Called up share capital	6	100
Retained earnings		28,459
Shareholders' funds		28,559

For the financial period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 2 June 2026
 

......................................... Graeme Arthur Peacock Director

Collabio Ltd

trading as Collabio

Notes to the Unaudited Financial Statements for the Period from 7 October 2024 to 31 October 2025

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
4 Livings Way
Stansted
CM24 8SN
England

These financial statements were authorised for issue by the director on 2 June 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Collabio Ltd

trading as Collabio

Notes to the Unaudited Financial Statements for the Period from 7 October 2024 to 31 October 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Office equipments	25% straight line
Furniture and Fittings	20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3	Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

Collabio Ltd

trading as Collabio

Notes to the Unaudited Financial Statements for the Period from 7 October 2024 to 31 October 2025

4	Tangible assets

	Fixtures and fittings £	Office equipment £	Total £
Cost or valuation
Additions	1,565	5,262	6,827
At 31 October 2025	1,565	5,262	6,827
Depreciation
Charge for the period	313	1,315	1,628
At 31 October 2025	313	1,315	1,628
Carrying amount
At 31 October 2025	1,252	3,947	5,199

5

Creditors

Creditors: amounts falling due within one year

	2025 £
Due within one year
Taxation and social security	13,150
Accruals and deferred income	59,021
Other creditors	8,726
	80,897

6	Share capital

Allotted, called up and fully paid shares

	2025
	No.	£
Ordinary shares of £1 each	100	100

7

Dividends

Interim dividends paid

Collabio Ltd

trading as Collabio

Notes to the Unaudited Financial Statements for the Period from 7 October 2024 to 31 October 2025

		2025 £
Interim dividend of £10.00 per each Ordinary shares		1,000

8	Related party transactions

Director's remuneration

The director's remuneration for the period was as follows:

	2025 £
Remuneration	7,332